Prefilled Syringes Market

Prefilled Syringes Market (7th Edition), Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Respiratory Disorders, Neurological Disorders, Metabolic Disorders, Ophthalmic Disorders, Orthopedic Disorders and Others), Type of Molecule (Therapeutic Syringes - Proteins, Antibodies, Peptides, Small Molecules, Vaccines and Cell Therapies), Type of Barrel Material (Glass Syringes and Plastic Syringes), Number of Barrel Chamber (Single Chamber Syringes and Dual Chamber Syringes), Type of Needle System (Staked Needle Syringes and Luer Syringes), Usability of Syringe (Disposable Syringes and Reusable Syringes), Type of Syringe (Conventional Syringes and Safety Syringes), Type of Packaging (Bulk Syringes and Nested Syringes) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America)

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    292

  • Pages
    867

  • View Count
    36606

We are seeing an increased demand in the emerging markets, particularly within the BRICS nations, namely Brazil, Russia, India, China and South Africa. North Africa and the Middle East also present a similar scenario, characterized by a growth rate of 10-18% for prefilled syringes

-- Marketing Director, a large-sized company

Prefilled Syringes Market Size

The global prefilled syringes market size is estimated to grow from USD 3,024 million in 2024 to USD 4,972 million by 2035, representing a CAGR of 4.6% during the forecast period 2024-2035. The new research study consists of industry trends, detailed market analysis, combination product analysis, likely drug candidates and likely partner analysis, patent analysis, market impact analysis and market forecast and opportunity analysis. The growth in the prefilled syringes market size over the next decade is likely to be the result of anticipated increase in adoption of self-injection devices and growing prevalence of chronic disorders requiring regular and long-term treatment.

Global Prefilled Syringes Market (USD Million)

To learn more about this report, request a free sample copy

The prevalence of various chronic disorders, such as autoimmune disorders (including rheumatoid arthritis), cardiovascular disorders, diabetes and oncological disorders has increased in recent years, across the world. In the US, in 2022, close to 133 million individuals suffered from one or more chronic disorders and this number is likely to reach 170 million, by 2030. As per a recent study conducted by the US Centers for Disease Control (CDC), the annual cost burden associated with chronic disorders in the US is USD 4.1 trillion. A major share of the expenses incurred by patients suffering from chronic diseases is driven by the frequent need to take the medication, thereby necessitating regular hospital visits. Further, hesitance of individuals to receive injections in a clinical setting due to privacy concerns or discomfort is another challenge for patients which affects patient compliance and adherence to the treatment regimen. In order to mitigate these challenges, a variety of self-administering devices have been developed (including autoinjectors, prefilled syringes and pen injectors); amongst these, prefilled syringes have steadily gained prominence, especially in the treatment of emergency situations, such as anaphylactic shock and rheumatoid arthritis.

Prefilled syringes are a type of primary packaging system that are pre-loaded with a precise dose of parenteral medication (in a ready to inject format), eliminating the need for manual filling. They offer various advantages including convenient usage, dose precision, reduced risk of contamination and minimum drug wastage. These drug delivery devices help in reduction of number of patients’ visits to the healthcare provider, thereby reducing the costs associated with global healthcare. Presently, different types of prefilled syringes are available in the market, including dual chamber prefilled syringes (such syringes store liquid and lyophilized components in different chambers), flush syringes (syringes containing sterile solution that is used to clear intravenous catheters, cannulas or other vascular access devices), and safety syringes (syringes equipped with mechanisms that prevent needlestick injuries and ensure safety of the healthcare worker). With the rising adoption of self-injecting parenteral devices, ongoing advancements in the technologies and growing preference for home healthcare services, the global prefilled syringes market is likely to grow, in the foreseen future.

Market Share Insights

The prefilled syringes research report presents an in-depth analysis of the various companies that are engaged in the global prefilled syringes industry, across different segments, as defined in the table below:

Global Prefilled Syringes Market: Report Attributes / Market Segmentation

Key Report Attribute Details
Historical Trend 2018-2022
Base Year 2023
Forecast Period 2024-2035
Market Size 2024 $3 Billion
Market Size 2035 $5 Billion
CAGR 4.6%
Purpose of Syringe
  • Specialty Prefilled Syringes 
  • Therapeutic Prefilled Syringes
  • Cosmetic Prefilled Syringes
Therapeutic Area (Therapeutic Syringes)
  • Blood Disorders
  • Infectious Diseases
  • Autoimmune Disorders
  • Oncological Disorders
  • Cardiovascular Disorders
  • Respiratory Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Ophthalmic Disorders
  • Orthopedic Disorders
  • Others
Type of Molecule (Therapeutic Syringes)
  • Proteins
  • Antibodies
  • Peptides
  • Small Molecules
  • Vaccines
  • Cell Therapies
Type of Barrel Material
  • Glass Syringe
  • Plastic Syringe
Number of Barrel Chamber
  • Single Chamber Syringe
  • Dual Chamber Syringe
Type of Needle System
  • Staked Needle Syringe
  • Luer Syringe
Usability of Syringe
  • Disposable Syringe
  • Reusable Syringe
Type of Syringe
  • Conventional Syringe
  • Safety Syringe
Type of Packaging
  • Bulk Syringe
  • Nested Syringe
Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America
Key Companies Profiled 
  • Becton Dickinson and Company
  • Credence MedSystems
  • Gerresheimer
  • J.O.Pharma
  • Medefil
  • MedXL
  • Mitsubishi Gas Chemical
  • Nipro PharmaPackaging
  • Novartis
  • Pfizer
  • SCHOTT
  • Shandong Pharmaceutical Glass
  • Shandong Weigao
  • Shin Yan Sheno Precision Industrial
  • Stevanato
  • Taisei Kako
  • Vetter Pharma
  • West Pharmaceutical 
(Full list of 30+ companies captured is available in the report)
PowerPoint Presentation
(Complimentary)
Available
Customization Scope

15% Free Customization

Excel Data Packs (Complimentary)
  • Market Landscape 
  • Product Competitiveness Analysis 
  • Combination Products
  • Likely Drug Candidate Analysis
  • Combination Products: Big Pharma Activity
  • Recent Developments
  • Patent Analysis
  • KOL Analysis
  • Market Forecast and Opportunity Analysis

 

One of the key objectives of this market report was to estimate the current market size, opportunity and the future growth potential of the prefilled syringes market, over the forecast period. We have provided informed estimates on the likely evolution of the market for the forecast period, 2023-2035.

Our year-wise projections of the current and future opportunity for pre filled syringes market have been segmented based on relevant parameters, such as purpose of syringe (specialty prefilled syringes, therapeutic prefilled syringes and cosmetic prefilled syringes), therapeutic area (therapeutic syringes - blood disorders, infectious diseases, autoimmune disorders, oncological disorders, cardiovascular disorders, respiratory disorders, neurological disorders, metabolic disorders, ophthalmic disorders, orthopedic disorders and others), type of molecule (therapeutic syringes - proteins, antibodies, peptides, small molecules, vaccines and cell therapies), type of barrel material (glass syringes and plastic syringes), number of barrel chamber (single chamber syringes and dual chamber syringes), type of needle system (staked needle syringes and luer syringes), usability of syringe (disposable syringes and reusable syringes), type of syringe (conventional syringes and safety syringes), type of packaging (bulk syringes and nested syringes) and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America).

Prefilled Syringes Market, Distribution by Key Geographical Regions

In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.

The opinions and insights presented in the market report were influenced by discussions held with several stakeholders in this industry. The report features detailed transcripts of interviews (in reverse chronological order) held with the following key industry stakeholders:

  • Founder and Chief Technology Officer, Small Company, UK
  • Chief Operating Officer, Very Large Company, India
  • Former Chief Commercial Officer, Large Company, Germany 
  • Former Director, Pharmaceutical Delivery Systems Marketing, and  Senior Director, Product Technology Services, Large Company, US
  • Head of R&D and Product Strategy, Small Company, Switzerland
  • Jesse Fourt, Design Director, Large Company, US 
  • Chief Executive Officer, Small Company

Further, all actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market report are in USD, unless otherwise specified.

Market Segmentation Overview

Market Share by Purpose of Syringe

The global prefilled syringes market highlights the distribution across different purpose, such as specialty syringes, therapeutic syringes and cosmetic pre-filled syringes. The specialty syringes segment occupies the highest share in 2024 and is expected to witness substantial growth in the coming years.

Market Share by Type of Needle System

The global prefilled syringes market is categorized into staked needle syringes and luer syringes, based on the type of needle system. Among these segments, staked needle syringe captures the majority share in the market. This can be attributed to the fact that these syringes are convenient to use, have low risk of needle detachment and are preferred in emergency medical conditions. However, the market for luer syringe is expected to grow at a faster pace in comparison to staked needle syringes in the near future.

Market Share by Usability of Syringe

The global prefilled syringes market is segmented into disposable syringes and reusable syringes. Currently, the disposable prefilled syringes capture maximum share (77%) of the overall market; however, the market for reusable prefilled syringes is likely to grow at a relatively faster pace in the next decade.

Market Share by Type of Syringe

The global prefilled syringes market highlights the distribution across different types of syringes into conventional syringes and safety syringes. Currently, around 70% market share is captured by safety prefilled syringes; this can be attributed to the fact that safety syringes reduce the risk of needlestick injuries and increase the safety of patients as well as healthcare workers.

Market Share by Geography

This segment highlights the distribution of prefilled syringes market across various geographies, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. According to our projections, the prefilled syringes market in Europe is likely to capture the majority market share (~50%), and this trend is unlikely to change in the future. Additionally, the prefilled syringes market in Asia-Pacific is expected to grow at a relatively high CAGR (7%), during the forecast period, 2024-2035.

Prefilled Syringes Market List

Key Market Insights

The “Prefilled Syringes Market (7th Edition), Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Respiratory Disorders, Neurological Disorders, Metabolic Disorders, Ophthalmic Disorders, Orthopedic Disorders and Others), Type of Molecule (Therapeutic Syringes - Proteins, Antibodies, Peptides, Small Molecules, Vaccines and Cell Therapies), Type of Barrel Material (Glass Syringes and Plastic Syringes), Number of Barrel Chamber (Single Chamber Syringes and Dual Chamber Syringes), Type of Needle System (Staked Needle Syringes and Luer Syringes), Usability of Syringe (Disposable Syringes and Reusable Syringes), Type of Syringe (Conventional Syringes and Safety Syringes), Type of Packaging (Bulk Syringes and Nested Syringes) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America)” report features an extensive study of the current market landscape, market size and future opportunities within the prefilled syringes industry, during the forecast period. The market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Key takeaways of the prefilled syringe market report are briefly discussed below.

Current Prefilled Syringes Market Landscape

The pre-filled syringes market features around 125 prefilled syringes. Close to 70% of the prefilled syringes use glass as the barrel material. Further, around 90% of the prefilled syringes are being developed in single chamber format; however, a shift towards the development of prefilled syringes in dual chamber format is being observed. Notably, dual chamber prefilled syringes offer various benefits, including enhanced drug stability, improved shelf life and reduced risk of contamination.

The current pre-filled syringes market landscape features the presence of 35 players that have the required expertise to develop and manufacture prefilled syringes. Overall, the market seems to be well-fragmented, comprising of very large, large, mid-sized, small and very small prefilled syringe manufacturers. Over 40% of the companies have their prefilled syringe manufacturing facilities based in Asia-Pacific, followed by Europe (33%) and North America (25%).

Prefilled Syringes Market Manufacturers


Prefilled Syringes Market Trends: Patent Filing to Foster Progress and Innovation

Over the years, majority of the patents filed by the industry stakeholders for prefilled syringes and related components have been focused on improving patient safety, eliminating dosing errors and bringing technological advancement. Notably, more than 1,300 patents have been filed in this domain, since 2019; of these, around 40% are granted patents. Interestingly, maximum number of patents in this domain have been filed by Becton Dickinson, followed by Terumo and Sanofi.

Prefilled Syringes Market Trends: Technological Advancements

  • Material Innovations: Players in the prefilled syringes market are exploring innovative materials to protect the quality, enhance the stability and shelf life, and eliminate interaction of the stored drug with the packaging materials (such as tungsten or silicone residues). For instance, Gerresheimer Biological Solutions uses a ceramic pin specifically for tungsten-sensitive products. In addition, SCHOTT ag’s syriQ BioPure silicone-free syringes, when combined with ImproJect plungers (from W.L. Gore & Associates), offer a silicone-free product compatible with sensitive products.
  • Needle Safety Mechanisms: Prefilled syringes are associated with needle stick injuries that can be caused due to accidental puncture while handling, administration or disposal of the prefilled syringes; these injuries pose significant risks to patients, healthcare professionals and individuals involved in the medical waste disposal process. In order to prevent these injuries, the players in this domain have either incorporated retractable needles (that automatically retracts into the syringe barrel post-injection) or started using needle shielding systems (that cover the needle post-use). For instance, Ompi syringes (developed by Stevanato) offer an integrated safety system for its staked needle syringes.
  • Smart Prefilled Syringes: The industry is witnessing the integration of smart technologies into prefilled syringes, thereby enhancing their functional value and allowing data tracking. For instance, Med-ic® SyringePack ECM™, which tracks the temperature history of prefilled syringes, and ensures product integrity at the time of use and adherence to medication. Further, in November 2022, Schreiner MediPharm (in collaboration with SCHOTT Pharma) launched RFID-equipped prefilled syringes that allow optimization of processes in hospital inventory management and patient care, and enables easy identification of medication and medical devices.
  • Automated Fill/Finish Operations: Innovations in the fill/finish process for prefilled syringes focus on automated equipment in order to ensure high efficiency, greater flexibility,  secure drug integrity and provide faster return on investment.

Prefilled Syringes Market Analysis

The global pre-filled syringes market size is estimated to be worth $2,895 million in 2024. Further, driven by the rise in incidence of chronic diseases, growing need for novel biologics and biosimilars, and rising demand for self-injection devices, the PFS market is anticipated to grow at a CAGR of 4.7% during the forecast period. In 2024, the majority share (49%) of the pre-filled syringes market is anticipated to be captured by companies based in Europe, followed by the share captured by companies headquartered in North America (24%) and Asia-Pacific (19%).
 

Prefilled Syringes Market Share Analysis: Glass Prefilled Syringes Holds the Largest Share

The prefilled syringes market is currently driven by the glass prefilled syringes; this trend is likely to remain the same in the coming future. In terms of number of chambers, single chamber prefilled syringes dominate the pre-filled syringes market, capturing a share of over 70% in the current market; however, the dual chambered prefilled syringes market is likely to grow at a faster pace, till 2035. Presently, in terms of type of needle system, maximum market share (60%) is captured by staked needle syringe, while 40% is captured by luer syringe.

Prefilled Syringes Market, Phase of Development

Leading Prefilled Syringe Manufacturers

Examples of key players (which have also been profiled in this report) engaged in manufacturing prefilled syringes include (in alphabetical order) Becton Dickinson and Company, Credence MedSystems, Gerresheimer, J.O.Pharma, Medefil, MedXL, Mitsubishi Gas Chemical, Nipro PharmaPackaging, Novartis, Pfizer, SCHOTT ag, Shandong Pharmaceutical Glass, Shandong Weigao, Shin Yan Sheno Precision Industrial, Stevanato, Taisei Kako, Vetter Pharma and West Pharmaceutical.

Further, examples of other key players involved in the fabrication and supply of elastomeric closures for prefilled syringes (in alphabetical order) include Aptar, Datwyler, Stevanato and West Pharmaceutical. In addition, some prominent players that are actively involved in providing fill / finish services for prefilled syringes include (in alphabetical order) Alkermes, Baxter Bipharma (a subsidiary of baxter international), Berkshire Sterile Manufacturing, Biocon, Carbogen Amics, Curia, Emergent BioSolutions, Fresenius Kabi and Singota Solutions. This prefilled syringes market report also includes an easily searchable excel database of all the companies manufacturing prefilled syringes and their closures, worldwide.


Report Coverage

The prefilled syringes market report presents an in-depth analysis, highlighting the capabilities of various firms in the prefilled syringe market, across different segments, as defined below: Amongst other elements, the market report features:

  • A preface providing an introduction to the full report, Prefilled Syringes Market (7th Edition), till 2035.
  • An outline of the systematic research methodology adopted to conduct the study on prefilled syringes, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
  • An overview of economic factors that impact the overall pre-filled syringes market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
  • An executive summary of the insights captured during our research. It offers a high-level view on the current state of the prefilled syringes market and its likely evolution in the mid-long term.
  • A general overview of prefilled syringes and their components, their historical evolution and advantages offered. The chapter also provides information on different types of prefilled syringes, based on barrel fabrication material, number of barrel chambers, type of needle system and type of packaging. It also outlines the manufacturing process for prefilled syringes, along with the future perspective of this domain. 
  • A detailed assessment of the current market landscape of prefilled syringes, based on several relevant parameters, such as type of barrel fabrication material (glass prefilled syringe and plastic prefilled syringe), number of barrel chamber (single chamber and dual chamber), type of needle system (staked needle, luer lock, luer cone and others) and volume of syringe (less than 2.1ml, 2.1 ml to 5 ml, 5.1 ml to 10 ml, and more than 10 ml). Further, the chapter provides a detailed analysis of prefilled syringe manufacturers, along with information on their year of establishment, company size (in terms of employee count), location of headquarters, location of their manufacturing facilities and most active players (in terms of number of prefilled syringes manufactured).
  • An insightful competitiveness analysis of prefilled syringes, based on manufacturer strength (in terms of company size and experience of the manufacturer) and product strength (in terms of stage of development, number of barrel chambers and volume of syringe available) and number of type of needle system.
  • Elaborate profiles of prominent prefilled syringes manufacturer (shortlisted based on our proprietary criterion) based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company (including information on year of establishment, location of headquarters, number of employees and leadership team), details related to its financial information (if available), prefilled syringes portfolio, recent developments and an informed future outlook. In addition to the leading prefilled syringe manufacturers, some other prominent players have also been profiled, for which information on company overview and prefilled syringe portfolio has been provided.
  • The chapter discusses the growing concern associated with needlestick injuries and the various steps (including regional and global legislations) that have been taken to prevent these mishaps. In addition, it provides detailed information on the various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes, and the companies engaged in development and manufacturing of such solutions.
  • An informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries / geographical regions.
  • A detailed analysis of various combination products that are either being evaluated or available in the form of prefilled syringes, primarily focusing on injectable drugs and vaccines. It includes detailed analyses of the approved drugs, based on several relevant parameters, such as type of drug molecule, year of approval, region of approval, route of administration and target therapeutic area. It also includes analysis for products that are in clinical stage, for parameters such as type of drug molecule, phase of development, route of administration and target therapeutic area. Further, the chapter provides information on drug developers engaged in developing these products, along with information on their year of establishment, company size, location of headquarters and location of manufacturing facilities.
  • An extensive discussion on the most commonly targeted therapeutic indications, including information on the approved / marketed injectable drug products available for the treatment of such clinical conditions (across different target therapeutic areas) and their respective biosimilars.
  • An in-depth analysis of marketed drugs / therapies that are likely to be available in prefilled syringe format in the near future, based on several relevant parameters, such as historical annual sales information, type of drug molecule, therapeutic area, route of administration and other available dosage forms. 
  • A review of the various prefilled syringe combination product-related initiatives undertaken by big pharma players (shortlisted on the basis of revenues generated in 2022), based on various parameters, such as number of prefilled syringe combination products (approved and under development), target therapeutic area and type of drug molecule.
  • A detailed analysis of recent developments in the prefilled syringes domain, based on relevant parameters such as year of initiative, type of initiative (partnerships and collaborations, expansions, funding and product launches), geographical distribution and most active players (in terms of number of recent developments).
  • An in-depth analysis of patents related to prefilled syringes, filed / granted, since 2019, based on the type of patent (granted patents, patent applications and others), publication year, application year, type of applicant, geographical location, CPC symbols and most active players (in terms of the number of patents filed / granted). In addition, the chapter includes patent benchmarking and an insightful patent valuation analysis, highlighting the leading patents (in terms of number of citations).
  • An analysis highlighting the key opinion leaders (KOLs) in this domain, based on several relevant parameters, such as role of KOL, type of sponsor organization, affiliated organization, target indication and geographical location of KOLs. In addition, the chapter highlights the most prominent KOLs, based on our proprietary scoring criteria.
  • Elaborative information on specialty syringes, namely prefilled flush syringes, prefilled diluent systems and prefilled syringes with contrast agents. For each type of specialty syringe, we have provided a brief overview, along with details on the different products that are available in the market and their advantages.
  • A detailed description of the recent technological advancements in this domain and their applications. The chapter highlights the advancements in design technology and manufacturing of prefilled syringes, that have enabled pharmaceutical companies to market lyophilized drugs in dual chambered syringe systems. The chapter also highlights novel lubrication and sterilization technologies.
  • A detailed discussion on the various factors that are anticipated to drive growth within the PFS market, such as increase in incidence of chronic diseases, rising preference for self-administration of medications, evolving patient landscape, introduction and growing adoption of biologics / biosimilars, evolving pharmaceutical strategies, initiatives focused on the prevention of needlestick injuries and the various potential applications of prefilled syringes. 
  • A discussion on industry affiliated trends, opportunities and challenges, under a SWOT analysis, which are likely to impact the evolution of prefilled syringes market; it includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on industry dynamics. 
  • A detailed market forecast analysis in order to estimate the existing prefilled syringes market size and future opportunity in the prefilled syringes market, over the next decade. Based on multiple parameters, such as likely adoption trends and through primary validations, we have provided an informed estimate on the market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the prefilled syringes market. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
  • Detailed projections of the current and future prefilled syringes market by different purposes of prefilled syringes, such as specialty syringes, therapeutic syringes and cosmetic syringe
  • Detailed projections of the current and future prefilled syringes market (specifically therapeutic syringes) across different therapeutic areas, such as blood disorders, infectious diseases, autoimmune disorders, oncological disorders, cardiovascular disorders, respiratory disorders, neurological disorders, metabolic disorders, ophthalmic disorders, orthopedic disorders and other disorders.
  • Detailed projections of the current and future prefilled syringes market (specifically therapeutic syringes) across different types of molecules, such as proteins, antibodies, peptides, small molecules, vaccines and cell therapies.
  • Detailed projections of the current and future prefilled syringes market across different types of barrel material, such as glass syringe and plastic syringe.
  • Detailed projections of the current and future prefilled syringes market across different number of chambers, such as single chamber syringe and double chamber syringe.
  • Detailed projections of the current and future prefilled syringes market across different types of needle systems, such as staked needle syringe and luer syringe.
  • Detailed projections of the current and future prefilled syringes market across usability of syringe, such as disposable syringe and reusable syringe.
  • Detailed projections of the current and future prefilled syringes market across different types of syringes, such as conventional syringe and safety syringe.
  • Detailed projections of the current and future prefilled syringes market across different types of packaging, such as bulk syringe and nested syringe.
  • Detailed projections of the current and future prefilled syringes market across various geographies, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America.
  • Elaborate profiles of prominent prefilled syringe component manufacturers, featuring a brief overview of the company (including information on year of establishment, location of headquarters, number of employees and leadership team), details related to its financial information (if available), prefilled syringes portfolio, recent developments and an informed future outlook.
  • A detailed overview of the steps involved in fill / finish process of prefilled syringes, and different methods and technologies used for filling prefilled syringes. Further, the chapter provides an analysis of the players offering contract fill / finish services for prefilled syringes, based on a number of several relevant parameters, such as year of establishment, location of headquarters, type of drug molecule (biologics and small molecules), and scale of operation (preclinical, clinical and commercial). 
  • A detailed case study of companies engaged in the manufacturing of autoinjectors, featuring brief profiles of key players in this domain and information on their respective product portfolio.

Recent Developments in Prefilled Syringes Market

Several recent developments have taken place in the field of prefilled syringes, some of which are been outlined below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we have outlined in our analysis.

  • In October 2023, West Pharmaceutical Services participated in 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference, held in Gothenburg, Sweden to showcase its expertise in large volume delivery systems, self-injection devices and pre-fillable syringe components.
  • In August 2023, Becton Dickinson expanded its collaboration with Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation (CIFF) and Pfizer to deliver over 320 million doses of Pfizer’s injectable contraceptive, Sayana® Press, which is administered by BD’s Uniject™ Auto-Disable Prefillable Injection System, through 2030.
  • In July 2023, Fresenius Kabi launched Simplist® Ready-to-Administer Prefilled Syringes comprising of Fentanyl Citrate Injection.
  • In May 2023, Becton Dickinson expanded the customer availability of its prefilled flush syringe with an integrated disinfection unit.
  • In May 2023, SCHOTT AG launched pre-fillable syringes made from advanced, pharmaceutical-grade polymers to deliver deep-cold drugs.
  • In May 2023, Medefil launched Atropine Sulfate Injection, USP, 1 mg/10 mL to treat bradyasystolic cardiac arrest.

Author(s): Simran Kaur and Rishav Thakur

Frequently Asked Questions

Question 1: What is prefilled syringe?

Answer: A prefilled syringe is a type of syringe pre-filled with a specific amount of medication, which eliminates the need of filling the drug prior to administration.

Question 2: Which materials are used for prefilled syringes?

Answer: Prefilled syringes barrels are generally manufactured using glass or plastic.

Question 3: What are the benefits of prefilled syringes?

Answer: Prefilled syringes offer various benefits, such as increased efficiency, improved safety, better drug stability and increased patient comfort.

Question 4: Who are the end users of prefilled syringes?

Answer: The end users of prefilled syringes include patients, clinical research organizations, healthcare professionals, and hospitals and clinics.

Question 5: Who are the leading key players in prefilled syringe industry?

Answer: The leading players in prefilled syringes industry include (arranged in decreasing order of number of products manufactured) Shandong Zibo Minkang Pharmaceutical Packing, Taisei Kako, becton dickinson, schott ag, SCHOTT POONAWALLA, Shin Yan Sheno Precision Industrial, Gerresheimer and Shandong Pharmaceutical Glass.

Question 6: How big is the global prefilled syringes market?

Answer: The prefilled syringes market size is anticipated to be worth USD 3,024 million in 2024.

Question 7: What is the global prefilled syringes market size likely to be in 2035?

Answer: The prefilled syringes market size is anticipated to be around USD 4,972 million in 2035.

Question 8: What is the prefilled syringe market growth?

Answer: The global prefilled syringes market is expected to grow at a CAGR of 4.6% during 2024-2035.

Question 9: What is the current market for dual chamber prefilled syringes market?

Answer: The global dual chamber prefilled syringes market is anticipated to be USD 890 million in 2024 and is expected to grow at a CAGR of 6.8%, till 2035.

Question 10: What is the market of disposable syringes?

Answer: The disposable syringes market size is anticipated to be worth USD 2.33 billion in 2024 and is expected to reach USD 3.06 billion in 2035.

Question 11: What is the market for syringes, in terms of therapeutic area?

Answer: Presently, blood disorders dominate the prefilled syringes market, capturing close to 65% of the overall share of therapeutic syringes.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com